(Prenatal) DES exposure various and/or opposite effects on body weight (pro- or anti-adipogenic effects) may depend on the time of exposure, on the sex of the exposed, and on non-monotonic aspects of the dose–response curve.
- 2017 Endocrine Disruptors and Obesity.
- 2017 Genetic variation in low-dose effects of neonatal DES exposure in female rats.
- 2017 Obesogenic endocrine disruptors and obesity: myths and truths.
- 2015 EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals.
- 2015 Prenatal diethylstilbestrol exposure and risk of obesity in adult women.
- 2014 Pharmacologic sex hormones in pregnancy in relation to offspring obesity.
- 2012 Diethylstilboestrol—A long-term legacy.
- 2012 Endocrine disruptors and obesity: obesogens.
- 2012 The endocrine disruptor diethylstilbestrol induces adipocyte differentiation and promotes obesity in mice.
- 2011 Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity later in life.
- 2011 Endocrine disruptors: from endocrine to metabolic disruption.
- 2010 Impact of environmental endocrine disrupting chemicals on the development of obesity.
- 2009 Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement.
- 2009 Environmental Estrogens and Obesity.
- 2008 Diethylstilbesterol has gender-specific effects on weight gain and bone development in mice.
- 2008 Effects of endocrine disruptors on obesity.
- 2007 Developmental Exposure to Endocrine Disruptors and the Obesity Epidemic.
- 2007 Perinatal exposure to environmental estrogens and the development of obesity.
- 2007 Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis.
- 2005 Developmental exposure to estrogenic compounds and obesity.
- 2000 Endocrine modulators in the food chain and environment.
- 1998 Childhood influences on adult disease.
For different topics, please see Diethylstilbestrol DES Studies.